Encapsulation of IL-12 With an Ultra pH-sensitive Tumor Delivery Platform to Improve Tolerability & Promotes Antitumor Response
Time: 2:30 pm
day: Conference Day Two
Details:
- Overcoming narrow therapeutic indexes like IL-12 through targeted delivery
- Using ON-BOARD ultra-pH sensitive micelles to encapsulate IL-12 for safe delivery to tumor
- The ON-BOARD micelle’s tumor specificity has been clinically validated by pegsitacianine an intraoperative cancer imaging agent based on the same micelle technology
